Optimum Lymphadenectomy for Esophageal Cancer

2009461 citationsJournal Article

Authors

Nabil P. Rizk · Memorial Sloan Kettering Cancer Center

Hemant Ishwaran · Cleveland Clinic

Thomas W. Rice · Cleveland Clinic

Longqi Chen · Sichuan University

Paul H. Schipper · Fox Chase Cancer Center

Kenneth A. Kesler · The University of Texas MD Anderson Cancer Center

Simon Law

Abstract

Greater extent of lymphadenectomy was associated with increased survival for all patients with esophageal cancer except at the extremes (TisN0M0 and >or=7 regional lymph nodes positive for cancer) and well-differentiated pN0M0 cancer. Maximum 5-year survival is modulated by T classification: resecting 10 nodes for pT1, 20 for pT2, and >or=30 for pT3/T4 is recommended.

Topics & Keywords

Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes Esophageal and GI Pathology

UN Sustainable Development Goals

Life in Land

Publication Details

Published in: Annals of Surgery

Volume 251, Issue 1, pp. 46-50

DOI: 10.1097/sla.0b013e3181b2f6ee

Field-Weighted Citation Impact: 17.67